Prevalence and resistance of <i>Helicobacter pylori</i> in a predominantly Hispanic population

<i>H. pylori</i> infection appears to be associated with low socioeconomic status and poor living conditions early in life. Clarithromycin and levofloxacin based treatment regimens should be avoided as first line therapy in this region, particularly in patients of Latin American origin.